The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of intermediate clinical endpoints (ICE) as a primary efficacy endpoint in malignant melanoma.
 
Siva Narayanan
Stock and Other Ownership Interests - GlaxoSmithKline
Consulting or Advisory Role - Abbott (Inst); Celgene (Inst); Electrocore (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst); Shire (Inst); Teva (Inst)
 
Dong Shao
Consulting or Advisory Role - Abbott (Inst); Celgene (Inst); Electrocore (Inst); Incyte (Inst); Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst); Shire (Inst)
 
Anshul Shah
Consulting or Advisory Role - Abbott (Inst); Celgene (Inst); Electrocore (Inst); Incyte (Inst); Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst); Shire (Inst)
 
Vidya Ramesh
Consulting or Advisory Role - Abbott (Inst); Celgene (Inst); Electrocore (Inst); Incyte (Inst); Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst); Shire (Inst)